Frequencies for first 10,000 rows of indi_pt variable in indi2004q4 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL HYSTERECTOMY | 1 0.01 0.01 ABDOMINAL PAIN | 4 0.04 0.05 ABDOMINAL PAIN UPPER | 4 0.04 0.09 ABDOMINAL SYMPTOM | 1 0.01 0.10 ABNORMAL BEHAVIOUR | 8 0.08 0.18 ABSCESS | 3 0.03 0.21 ACARODERMATITIS | 2 0.02 0.23 ACCIDENT AT WORK | 1 0.01 0.24 ACCIDENTAL EXPOSURE | 1 0.01 0.25 ACIDOSIS | 1 0.01 0.26 ACNE | 17 0.17 0.43 ACNE CYSTIC | 2 0.02 0.45 ACNE PUSTULAR | 1 0.01 0.46 ACQUIRED IMMUNODEFICIENCY SYNDROME | 15 0.15 0.61 ACTINIC KERATOSIS | 1 0.01 0.62 ACUTE CORONARY SYNDROME | 3 0.03 0.65 ACUTE LYMPHOCYTIC LEUKAEMIA | 26 0.26 0.91 ACUTE MONOCYTIC LEUKAEMIA | 6 0.06 0.97 ACUTE MYELOID LEUKAEMIA | 36 0.36 1.33 ACUTE MYOCARDIAL INFARCTION | 11 0.11 1.44 ACUTE PROMYELOCYTIC LEUKAEMIA | 12 0.12 1.56 ACUTE PSYCHOSIS | 3 0.03 1.59 ACUTE RESPIRATORY DISTRESS SYNDROME | 1 0.01 1.60 ACUTE STRESS DISORDER | 1 0.01 1.61 ADENOCARCINOMA | 2 0.02 1.63 ADENOVIRUS INFECTION | 3 0.03 1.66 ADNEXA UTERI PAIN | 1 0.01 1.67 ADRENAL CARCINOMA | 1 0.01 1.68 ADRENAL INSUFFICIENCY | 1 0.01 1.69 ADULT T-CELL LYMPHOMA/LEUKAEMIA | 5 0.05 1.74 AFFECTIVE DISORDER | 4 0.04 1.78 AGE INDETERMINATE MYOCARDIAL INFARCTION | 2 0.02 1.80 AGGRESSION | 2 0.02 1.82 AGITATION | 16 0.16 1.98 ALCOHOL DETOXIFICATION | 1 0.01 1.99 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 1 0.01 2.00 ALOPECIA | 4 0.04 2.04 ALOPECIA AREATA | 1 0.01 2.05 AMENORRHOEA | 1 0.01 2.06 AMINO ACID LEVEL INCREASED | 1 0.01 2.07 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 2.08 ANAEMIA | 12 0.12 2.20 ANAEMIA OF MALIGNANT DISEASE | 7 0.07 2.27 ANAEMIA PROPHYLAXIS | 1 0.01 2.28 ANAESTHESIA | 27 0.27 2.55 ANAESTHESIA REVERSAL | 1 0.01 2.56 ANAESTHETIC PREMEDICATION | 4 0.04 2.60 ANAL CANCER | 2 0.02 2.62 ANAL CANCER METASTATIC | 3 0.03 2.65 ANAL FISTULA | 1 0.01 2.66 ANALGESIC EFFECT | 8 0.08 2.74 ANALGESIC THERAPY | 2 0.02 2.76 ANAPHYLACTIC SHOCK | 1 0.01 2.77 ANAPLASTIC ASTROCYTOMA | 1 0.01 2.78 ANGINA PECTORIS | 31 0.31 3.09 ANGINA UNSTABLE | 1 0.01 3.10 ANGIOGRAM | 4 0.04 3.14 ANGIOGRAM RETINA | 8 0.08 3.22 ANGIOPATHY | 2 0.02 3.24 ANGIOPLASTY | 6 0.06 3.30 ANKLE FRACTURE | 2 0.02 3.32 ANKYLOSING SPONDYLITIS | 29 0.29 3.61 ANTIBACTERIAL PROPHYLAXIS | 6 0.06 3.67 ANTICOAGULANT THERAPY | 5 0.05 3.72 ANTIEMETIC SUPPORTIVE CARE | 1 0.01 3.73 ANTIFUNGAL PROPHYLAXIS | 4 0.04 3.77 ANTIPHOSPHOLIPID SYNDROME | 2 0.02 3.79 ANTIPLATELET THERAPY | 4 0.04 3.83 ANTIVIRAL PROPHYLAXIS | 7 0.07 3.90 ANXIETY | 81 0.81 4.71 ANXIETY DISORDER | 4 0.04 4.75 AORTIC ANEURYSM | 1 0.01 4.76 AORTIC VALVE DISEASE | 3 0.03 4.79 APHERESIS | 1 0.01 4.80 APHTHOUS STOMATITIS | 1 0.01 4.81 APLASTIC ANAEMIA | 8 0.08 4.89 APNOEA | 1 0.01 4.90 APPENDICITIS PERFORATED | 1 0.01 4.91 ARRHYTHMIA | 16 0.16 5.07 ARRHYTHMIA PROPHYLAXIS | 1 0.01 5.08 ARTERIAL DISORDER | 1 0.01 5.09 ARTERIOGRAM CORONARY | 3 0.03 5.12 ARTERIOSCLEROSIS | 3 0.03 5.15 ARTERITIS | 5 0.05 5.20 ARTHRALGIA | 86 0.86 6.06 ARTHRITIS | 227 2.27 8.33 ARTHROGRAM | 1 0.01 8.34 ARTHROPATHY | 10 0.10 8.44 ARTHROSCOPIC SURGERY | 1 0.01 8.45 ARTHROSCOPY | 1 0.01 8.46 ASCITES | 3 0.03 8.49 ASPERGILLOSIS | 1 0.01 8.50 ASTHMA | 121 1.21 9.71 ASTROCYTOMA | 1 0.01 9.72 ATHEROSCLEROSIS | 1 0.01 9.73 ATHEROSCLEROSIS OBLITERANS | 4 0.04 9.77 ATRIAL FIBRILLATION | 51 0.51 10.28 ATRIAL FLUTTER | 6 0.06 10.34 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 38 0.38 10.72 AUTISM | 3 0.03 10.75 AUTOIMMUNE THYROIDITIS | 2 0.02 10.77 AUTOLOGOUS BONE MARROW TRANSPLANTATIO.. | 1 0.01 10.78 B-CELL LYMPHOMA | 4 0.04 10.82 B-CELL LYMPHOMA STAGE II | 6 0.06 10.88 BACK DISORDER | 3 0.03 10.91 BACK INJURY | 8 0.08 10.99 BACK PAIN | 116 1.16 12.15 BACTERIA URINE IDENTIFIED | 1 0.01 12.16 BACTERIAL INFECTION | 2 0.02 12.18 BARRETT'S OESOPHAGUS | 2 0.02 12.20 BENIGN PROSTATIC HYPERPLASIA | 19 0.19 12.39 BILE OUTPUT INCREASED | 1 0.01 12.40 BIOPSY SALIVARY GLAND | 1 0.01 12.41 BIPOLAR DISORDER | 38 0.38 12.79 BIPOLAR I DISORDER | 10 0.10 12.89 BIPOLAR II DISORDER | 2 0.02 12.91 BLADDER CANCER | 29 0.29 13.20 BLADDER PAIN | 1 0.01 13.21 BLEPHARITIS | 1 0.01 13.22 BLOOD CHOLESTEROL | 13 0.13 13.35 BLOOD CHOLESTEROL INCREASED | 62 0.62 13.97 BLOOD CREATININE INCREASED | 4 0.04 14.01 BLOOD GLUCOSE DECREASED | 1 0.01 14.02 BLOOD GLUCOSE INCREASED | 3 0.03 14.05 BLOOD HOMOCYSTEINE INCREASED | 2 0.02 14.07 BLOOD IMMUNOGLOBULIN G DECREASED | 1 0.01 14.08 BLOOD POTASSIUM INCREASED | 1 0.01 14.09 BLOOD PRESSURE | 22 0.22 14.31 BLOOD PRESSURE DECREASED | 2 0.02 14.33 BLOOD PRESSURE INCREASED | 9 0.09 14.42 BLOOD PRESSURE SYSTOLIC INCREASED | 1 0.01 14.43 BLOOD STEM CELL HARVEST | 1 0.01 14.44 BLOOD TESTOSTERONE DECREASED | 1 0.01 14.45 BLOOD TRIGLYCERIDES | 1 0.01 14.46 BLOOD TRIGLYCERIDES INCREASED | 3 0.03 14.49 BODY HEIGHT BELOW NORMAL | 3 0.03 14.52 BODY TINEA | 1 0.01 14.53 BONE DENSITY DECREASED | 3 0.03 14.56 BONE DISORDER | 2 0.02 14.58 BONE INFECTION | 2 0.02 14.60 BONE MARROW CONDITIONING REGIMEN | 11 0.11 14.71 BONE MARROW TRANSPLANT | 5 0.05 14.76 BONE PAIN | 11 0.11 14.87 BONE TUBERCULOSIS | 4 0.04 14.91 BORDERLINE PERSONALITY DISORDER | 1 0.01 14.92 BORRELIA INFECTION | 1 0.01 14.93 BOWEN'S DISEASE | 1 0.01 14.94 BRAIN ABSCESS | 1 0.01 14.95 BRAIN NEOPLASM | 3 0.03 14.98 BRAIN OEDEMA | 1 0.01 14.99 BREAST CANCER | 96 0.96 15.95 BREAST CANCER FEMALE | 2 0.02 15.97 BREAST CANCER IN SITU | 1 0.01 15.98 BREAST CANCER METASTATIC | 39 0.39 16.37 BREAST HYPERPLASIA | 2 0.02 16.39 BRIEF PSYCHOTIC DISORDER, WITH POSTPA.. | 2 0.02 16.41 BRONCHIAL CARCINOMA | 3 0.03 16.44 BRONCHIOLOALVEOLAR CARCINOMA | 2 0.02 16.46 BRONCHITIS | 22 0.22 16.68 BRONCHITIS ACUTE | 13 0.13 16.81 BRONCHITIS CHRONIC | 8 0.08 16.89 BRONCHOPNEUMONIA | 2 0.02 16.91 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 16.92 BRONCHOPULMONARY DISEASE | 3 0.03 16.95 BRONCHOSTENOSIS | 2 0.02 16.97 BRUXISM | 1 0.01 16.98 BURKITT'S LYMPHOMA STAGE IV | 2 0.02 17.00 BURSITIS | 9 0.09 17.09 C-REACTIVE PROTEIN INCREASED | 1 0.01 17.10 CAMPYLOBACTER INFECTION | 1 0.01 17.11 CANCER PAIN | 32 0.32 17.43 CANDIDA SEPSIS | 1 0.01 17.44 CANDIDIASIS | 2 0.02 17.46 CARCINOEMBRYONIC ANTIGEN INCREASED | 1 0.01 17.47 CARCINOMA | 11 0.11 17.58 CARDIAC ANEURYSM | 1 0.01 17.59 CARDIAC DISORDER | 13 0.13 17.72 CARDIAC FAILURE | 35 0.35 18.07 CARDIAC FAILURE CHRONIC | 1 0.01 18.08 CARDIAC FAILURE CONGESTIVE | 20 0.20 18.28 CARDIAC FIBRILLATION | 1 0.01 18.29 CARDIOMYOPATHY | 11 0.11 18.40 CARDIOVASCULAR DISORDER | 8 0.08 18.48 CARPAL TUNNEL SYNDROME | 4 0.04 18.52 CATHETER RELATED COMPLICATION | 2 0.02 18.54 CAUDA EQUINA SYNDROME | 1 0.01 18.55 CELLULITIS | 13 0.13 18.68 CEREBRAL INFARCTION | 3 0.03 18.71 CEREBRAL THROMBOSIS | 1 0.01 18.72 CEREBROVASCULAR ACCIDENT | 7 0.07 18.79 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 2 0.02 18.81 CERVICAL CORD COMPRESSION | 1 0.01 18.82 CERVIX CARCINOMA | 8 0.08 18.90 CERVIX CARCINOMA RECURRENT | 1 0.01 18.91 CERVIX NEOPLASM | 3 0.03 18.94 CHEILITIS | 1 0.01 18.95 CHEMOTHERAPY | 34 0.34 19.29 CHEMOTHERAPY NEUROTOXICITY ATTENUATION | 1 0.01 19.30 CHEST PAIN | 5 0.05 19.35 CHOLELITHIASIS | 2 0.02 19.37 CHROMOSOME ANALYSIS ABNORMAL | 1 0.01 19.38 CHRONIC FATIGUE SYNDROME | 1 0.01 19.39 CHRONIC HEPATITIS | 5 0.05 19.44 CHRONIC LYMPHOCYTIC LEUKAEMIA | 9 0.09 19.53 CHRONIC MYELOID LEUKAEMIA | 11 0.11 19.64 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE | 22 0.22 19.86 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE E.. | 1 0.01 19.87 CHRONIC SINUSITIS | 4 0.04 19.91 CIRCULATORY COLLAPSE | 2 0.02 19.93 CLAUSTROPHOBIA | 1 0.01 19.94 CLUSTER HEADACHE | 9 0.09 20.03 COAGULOPATHY | 2 0.02 20.05 COGNITIVE DISORDER | 1 0.01 20.06 COLITIS | 1 0.01 20.07 COLITIS ULCERATIVE | 3 0.03 20.10 COLON CANCER | 24 0.24 20.34 COLON CANCER METASTATIC | 17 0.17 20.51 COLONIC STENOSIS | 1 0.01 20.52 COLONOSCOPY | 2 0.02 20.54 COLORECTAL CANCER | 12 0.12 20.66 COLORECTAL CANCER METASTATIC | 36 0.36 21.02 COMPLETED SUICIDE | 12 0.12 21.14 COMPLEX PARTIAL SEIZURES | 1 0.01 21.15 COMPULSIONS | 2 0.02 21.17 COMPUTERISED TOMOGRAM | 4 0.04 21.21 COMPUTERISED TOMOGRAM ABDOMEN | 2 0.02 21.23 CONDITION AGGRAVATED | 1 0.01 21.24 CONFUSIONAL STATE | 5 0.05 21.29 CONGENITAL ANOMALY | 1 0.01 21.30 CONGENITAL APLASTIC ANAEMIA | 2 0.02 21.32 CONNECTIVE TISSUE DISORDER | 3 0.03 21.35 CONSTIPATION | 22 0.22 21.57 CONSTIPATION PROPHYLAXIS | 1 0.01 21.58 CONTRACEPTION | 65 0.65 22.23 CONTUSION | 1 0.01 22.24 CONVULSION | 55 0.55 22.79 CONVULSION PROPHYLAXIS | 2 0.02 22.81 CORONARY ANGIOPLASTY | 3 0.03 22.84 CORONARY ARTERIAL STENT INSERTION | 3 0.03 22.87 CORONARY ARTERY ATHEROSCLEROSIS | 1 0.01 22.88 CORONARY ARTERY DISEASE | 23 0.23 23.11 CORONARY ARTERY INSUFFICIENCY | 1 0.01 23.12 COSTOCHONDRITIS | 1 0.01 23.13 COUGH | 10 0.10 23.23 CRANIAL NEUROPATHY | 1 0.01 23.24 CROHN'S DISEASE | 81 0.81 24.05 CRUSH INJURY | 1 0.01 24.06 CYST | 1 0.01 24.07 CYSTINOSIS | 7 0.07 24.14 CYSTITIS | 5 0.05 24.19 CYSTITIS NONINFECTIVE | 1 0.01 24.20 CYTOMEGALOVIRUS CHORIORETINITIS | 1 0.01 24.21 CYTOMEGALOVIRUS INFECTION | 2 0.02 24.23 CYTOMEGALOVIRUS VIRAEMIA | 1 0.01 24.24 DECREASED APPETITE | 2 0.02 24.26 DEEP VEIN THROMBOSIS | 4 0.04 24.30 DEEP VENOUS THROMBOSIS PROPHYLAXIS | 9 0.09 24.39 DELUSION | 2 0.02 24.41 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 1 0.01 24.42 DEMENTIA | 16 0.16 24.58 DEMENTIA ALZHEIMER'S TYPE | 39 0.39 24.97 DENTAL CARE | 2 0.02 24.99 DENTAL OPERATION | 4 0.04 25.03 DEPRESSION | 237 2.37 27.40 DEPRESSIVE SYMPTOM | 4 0.04 27.44 DERMATITIS | 1 0.01 27.45 DERMATITIS ATOPIC | 6 0.06 27.51 DERMATITIS DIAPER | 1 0.01 27.52 DERMATOMYOSITIS | 8 0.08 27.60 DIABETES INSIPIDUS | 2 0.02 27.62 DIABETES MELLITUS | 111 1.11 28.73 DIABETES MELLITUS INSULIN-DEPENDENT | 15 0.15 28.88 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 63 0.63 29.51 DIABETIC GASTROPARESIS | 4 0.04 29.55 DIABETIC NEUROPATHY | 1 0.01 29.56 DIAGNOSTIC PROCEDURE | 2 0.02 29.58 DIALYSIS | 3 0.03 29.61 DIARRHOEA | 6 0.06 29.67 DIARRHOEA INFECTIOUS | 1 0.01 29.68 DIFFUSE LARGE B-CELL LYMPHOMA | 15 0.15 29.83 DISSEMINATED TUBERCULOSIS | 4 0.04 29.87 DIURETIC EFFECT | 2 0.02 29.89 DIURETIC THERAPY | 1 0.01 29.90 DIVERTICULITIS | 2 0.02 29.92 DIVERTICULUM | 1 0.01 29.93 DRUG DEPENDENCE | 5 0.05 29.98 DRUG EXPOSURE DURING PREGNANCY | 16 0.16 30.14 DRUG TOLERANCE | 1 0.01 30.15 DRUG USE FOR UNKNOWN INDICATION | 819 8.19 38.34 DRUG WITHDRAWAL MAINTENANCE THERAPY | 1 0.01 38.35 DUODENAL ULCER | 7 0.07 38.42 DUODENAL ULCER HAEMORRHAGE | 1 0.01 38.43 DUODENITIS | 3 0.03 38.46 DYSKINESIA | 2 0.02 38.48 DYSLIPIDAEMIA | 19 0.19 38.67 DYSMENORRHOEA | 3 0.03 38.70 DYSPEPSIA | 8 0.08 38.78 DYSPNOEA | 11 0.11 38.89 DYSTONIA | 1 0.01 38.90 DYSURIA | 1 0.01 38.91 EAR DISORDER | 1 0.01 38.92 EAR INFECTION | 7 0.07 38.99 EAR PAIN | 1 0.01 39.00 ECZEMA | 5 0.05 39.05 ELECTROLYTE SUBSTITUTION THERAPY | 1 0.01 39.06 EMBOLIC STROKE | 1 0.01 39.07 EMBOLISM | 1 0.01 39.08 EMOTIONAL DISORDER | 2 0.02 39.10 EMPHYSEMA | 1 0.01 39.11 ENDOCARDITIS | 6 0.06 39.17 ENDOCARDITIS CANDIDA | 1 0.01 39.18 ENDOMETRIOSIS | 1 0.01 39.19 ENDOSCOPY | 2 0.02 39.21 ENERGY INCREASED | 1 0.01 39.22 ENURESIS | 1 0.01 39.23 EPICONDYLITIS | 2 0.02 39.25 EPILEPSY | 103 1.03 40.28 EPISTAXIS | 2 0.02 40.30 ERECTILE DYSFUNCTION | 26 0.26 40.56 EROSIVE OESOPHAGITIS | 1 0.01 40.57 ESSENTIAL HYPERTENSION | 19 0.19 40.76 ESSENTIAL THROMBOCYTHAEMIA | 2 0.02 40.78 ESSENTIAL TREMOR | 1 0.01 40.79 EWING'S SARCOMA | 2 0.02 40.81 EX-SMOKER | 9 0.09 40.90 EXCITABILITY | 2 0.02 40.92 EXOSTOSIS | 3 0.03 40.95 EXTRADURAL ABSCESS | 1 0.01 40.96 EXTRASYSTOLES | 1 0.01 40.97 FABRY'S DISEASE | 4 0.04 41.01 FACTOR VIII DEFICIENCY | 2 0.02 41.03 FAECES HARD | 1 0.01 41.04 FALL | 1 0.01 41.05 FATIGUE | 2 0.02 41.07 FEBRILE NEUTROPENIA | 2 0.02 41.09 FEMORAL ARTERY OCCLUSION | 2 0.02 41.11 FIBROMYALGIA | 19 0.19 41.30 FISTULA | 1 0.01 41.31 FLATULENCE | 2 0.02 41.33 FLUID RETENTION | 3 0.03 41.36 FOLATE DEFICIENCY | 1 0.01 41.37 FRACTURE | 2 0.02 41.39 FRONTAL LOBE EPILEPSY | 5 0.05 41.44 FUNDOSCOPY | 4 0.04 41.48 FUNGAL INFECTION | 8 0.08 41.56 FUNGAL SKIN INFECTION | 1 0.01 41.57 GASTRIC BYPASS | 1 0.01 41.58 GASTRIC CANCER | 14 0.14 41.72 GASTRIC DISORDER | 2 0.02 41.74 GASTRIC MUCOSAL LESION | 1 0.01 41.75 GASTRIC ULCER | 11 0.11 41.86 GASTRITIS | 25 0.25 42.11 GASTROENTERITIS | 1 0.01 42.12 GASTROINTESTINAL CANCER METASTATIC | 2 0.02 42.14 GASTROINTESTINAL DISORDER | 1 0.01 42.15 GASTROINTESTINAL HAEMORRHAGE | 1 0.01 42.16 GASTROINTESTINAL STROMAL TUMOUR | 5 0.05 42.21 GASTROOESOPHAGEAL CANCER | 2 0.02 42.23 GASTROOESOPHAGEAL REFLUX DISEASE | 24 0.24 42.47 GASTROSCHISIS | 8 0.08 42.55 GAUCHER'S DISEASE | 4 0.04 42.59 GENERAL ANAESTHESIA | 7 0.07 42.66 GENERAL SYMPTOM | 2 0.02 42.68 GENERALISED ANXIETY DISORDER | 10 0.10 42.78 GENITAL DISORDER FEMALE | 1 0.01 42.79 GINGIVAL OPERATION | 1 0.01 42.80 GLAUCOMA | 18 0.18 42.98 GLIOBLASTOMA MULTIFORME | 3 0.03 43.01 GLOMERULONEPHRITIS | 1 0.01 43.02 GLOMERULONEPHRITIS PROLIFERATIVE | 1 0.01 43.03 GLYCOPEPTIDE ANTIBIOTIC RESISTANT ENT.. | 1 0.01 43.04 GOITRE | 2 0.02 43.06 GOUT | 19 0.19 43.25 GRAFT VERSUS HOST DISEASE | 2 0.02 43.27 GRAM STAIN POSITIVE | 1 0.01 43.28 GRAND MAL CONVULSION | 9 0.09 43.37 GROWTH HORMONE DEFICIENCY | 2 0.02 43.39 GUILLAIN-BARRE SYNDROME | 1 0.01 43.40 HAEMATEMESIS | 3 0.03 43.43 HAEMATURIA | 3 0.03 43.46 HAEMOLYTIC ANAEMIA | 1 0.01 43.47 HAEMOPHILIA | 1 0.01 43.48 HAEMORRHAGE | 1 0.01 43.49 HAEMORRHOIDS | 1 0.01 43.50 HAIRY CELL LEUKAEMIA | 1 0.01 43.51 HALLUCINATION | 3 0.03 43.54 HALLUCINATION, AUDITORY | 1 0.01 43.55 HEADACHE | 19 0.19 43.74 HEART DISEASE CONGENITAL | 2 0.02 43.76 HEART RATE | 1 0.01 43.77 HEART RATE DECREASED | 2 0.02 43.79 HEART RATE INCREASED | 1 0.01 43.80 HEART RATE IRREGULAR | 1 0.01 43.81 HEART TRANSPLANT | 9 0.09 43.90 HEART VALVE REPLACEMENT | 2 0.02 43.92 HELICOBACTER INFECTION | 6 0.06 43.98 HENOCH-SCHONLEIN PURPURA | 1 0.01 43.99 HEPARIN-INDUCED THROMBOCYTOPENIA | 2 0.02 44.01 HEPATIC CANCER METASTATIC | 3 0.03 44.04 HEPATIC CIRRHOSIS | 1 0.01 44.05 HEPATIC NEOPLASM MALIGNANT | 6 0.06 44.11 HEPATITIS ALCOHOLIC | 1 0.01 44.12 HEPATITIS B | 12 0.12 44.24 HEPATITIS C | 105 1.05 45.29 HEPATITIS C VIRUS | 2 0.02 45.31 HEPATO-LENTICULAR DEGENERATION | 3 0.03 45.34 HERPES SIMPLEX | 4 0.04 45.38 HERPES VIRUS INFECTION | 1 0.01 45.39 HERPES ZOSTER | 36 0.36 45.75 HIATUS HERNIA | 5 0.05 45.80 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 45.81 HIGH DENSITY LIPOPROTEIN INCREASED | 1 0.01 45.82 HIP ARTHROPLASTY | 2 0.02 45.84 HIP SURGERY | 2 0.02 45.86 HIV INFECTION | 307 3.07 48.93 HIV INFECTION CDC GROUP I | 1 0.01 48.94 HODGKIN'S DISEASE | 4 0.04 48.98 HORMONE LEVEL ABNORMAL | 1 0.01 48.99 HORMONE REPLACEMENT THERAPY | 235 2.35 51.34 HORNER'S SYNDROME | 1 0.01 51.35 HUMORAL IMMUNE DEFECT | 1 0.01 51.36 HYDROCEPHALUS | 1 0.01 51.37 HYPERCALCAEMIA | 2 0.02 51.39 HYPERCALCAEMIA OF MALIGNANCY | 1 0.01 51.40 HYPERCHLORHYDRIA | 3 0.03 51.43 HYPERCHOLESTEROLAEMIA | 68 0.68 52.11 HYPERGLYCAEMIA | 2 0.02 52.13 HYPERHIDROSIS | 1 0.01 52.14 HYPERLIPIDAEMIA | 48 0.48 52.62 HYPERPARATHYROIDISM SECONDARY | 4 0.04 52.66 HYPERPHOSPHATAEMIA | 6 0.06 52.72 HYPERSENSITIVITY | 18 0.18 52.90 HYPERTENSION | 508 5.08 57.98 HYPERTENSIVE CARDIOMYOPATHY | 4 0.04 58.02 HYPERTHYROIDISM | 5 0.05 58.07 HYPERTONIA | 9 0.09 58.16 HYPERTONIC BLADDER | 1 0.01 58.17 HYPERTRIGLYCERIDAEMIA | 3 0.03 58.20 HYPERTROPHIC CARDIOMYOPATHY | 1 0.01 58.21 HYPERURICAEMIA | 8 0.08 58.29 HYPOAESTHESIA | 5 0.05 58.34 HYPOALBUMINAEMIA | 3 0.03 58.37 HYPOGAMMAGLOBULINAEMIA | 1 0.01 58.38 HYPOKALAEMIA | 5 0.05 58.43 HYPOMANIA | 1 0.01 58.44 HYPOPHOSPHATAEMIA | 2 0.02 58.46 HYPOPITUITARISM | 1 0.01 58.47 HYPOTENSION | 2 0.02 58.49 HYPOTHYROIDISM | 23 0.23 58.72 HYPOTONIA | 1 0.01 58.73 HYPOTRICHOSIS | 1 0.01 58.74 HYSTERECTOMY | 1 0.01 58.75 ILL-DEFINED DISORDER | 317 3.17 61.92 IMMUNISATION | 1 0.01 61.93 IMMUNOSUPPRESSANT DRUG THERAPY | 3 0.03 61.96 IMMUNOSUPPRESSION | 11 0.11 62.07 IMPETIGO | 1 0.01 62.08 IN VITRO FERTILISATION | 7 0.07 62.15 INCONTINENCE | 1 0.01 62.16 INDUCTION OF ANAESTHESIA | 5 0.05 62.21 INFARCTION | 1 0.01 62.22 INFECTION | 16 0.16 62.38 INFECTION PROPHYLAXIS | 23 0.23 62.61 INFLAMMATION | 21 0.21 62.82 INFLAMMATORY BOWEL DISEASE | 1 0.01 62.83 INFLUENZA | 4 0.04 62.87 INFLUENZA LIKE ILLNESS | 2 0.02 62.89 INGUINAL HERNIA | 5 0.05 62.94 INJURY | 2 0.02 62.96 INSOMNIA | 52 0.52 63.48 INSULIN RESISTANCE | 1 0.01 63.49 INTENTIONAL MISUSE | 22 0.22 63.71 INTENTIONAL OVERDOSE | 2 0.02 63.73 INTERMITTENT CLAUDICATION | 4 0.04 63.77 INTERMITTENT EXPLOSIVE DISORDER | 3 0.03 63.80 INTERSTITIAL LUNG DISEASE | 3 0.03 63.83 INTERVERTEBRAL DISC DEGENERATION | 5 0.05 63.88 INTERVERTEBRAL DISC DISORDER | 4 0.04 63.92 INTERVERTEBRAL DISC DISPLACEMENT | 5 0.05 63.97 INTERVERTEBRAL DISC PROTRUSION | 12 0.12 64.09 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 64.10 INTESTINAL HYPOMOTILITY | 2 0.02 64.12 INTESTINAL PERFORATION | 1 0.01 64.13 INTESTINAL POLYP | 1 0.01 64.14 INTESTINAL SPASM | 1 0.01 64.15 INTRA-CEREBRAL ANEURYSM OPERATION | 1 0.01 64.16 INTRACRANIAL VENOUS SINUS THROMBOSIS | 1 0.01 64.17 INTRAUTERINE INFECTION | 1 0.01 64.18 IRITIS | 1 0.01 64.19 IRON DEFICIENCY | 1 0.01 64.20 IRON DEFICIENCY ANAEMIA | 4 0.04 64.24 IRRITABLE BOWEL SYNDROME | 32 0.32 64.56 ISCHAEMIC CARDIOMYOPATHY | 2 0.02 64.58 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 1 0.01 64.59 ISCHAEMIC STROKE | 2 0.02 64.61 JAW OSTEITIS | 1 0.01 64.62 JOINT ARTHROPLASTY | 1 0.01 64.63 JOINT EFFUSION | 1 0.01 64.64 JOINT INJURY | 4 0.04 64.68 JOINT SPRAIN | 1 0.01 64.69 JOINT SWELLING | 1 0.01 64.70 JUVENILE ARTHRITIS | 16 0.16 64.86 KELOID SCAR | 2 0.02 64.88 KERATOCONJUNCTIVITIS SICCA | 1 0.01 64.89 KIDNEY TRANSPLANT REJECTION | 2 0.02 64.91 KNEE OPERATION | 2 0.02 64.93 LABOUR INDUCTION | 8 0.08 65.01 LACRIMATION INCREASED | 1 0.01 65.02 LARYNGEAL CANCER | 1 0.01 65.03 LARYNGITIS | 1 0.01 65.04 LARYNGOTRACHEITIS | 1 0.01 65.05 LAXATIVE SUPPORTIVE CARE | 2 0.02 65.07 LEFT VENTRICULAR FAILURE | 3 0.03 65.10 LEIOMYOSARCOMA | 2 0.02 65.12 LEUKAEMIA PLASMACYTIC | 3 0.03 65.15 LEUKAEMIA RECURRENT PROPHYLAXIS | 4 0.04 65.19 LICE INFESTATION | 1 0.01 65.20 LICHEN SCLEROSUS | 5 0.05 65.25 LIMB INJURY | 2 0.02 65.27 LIP AND/OR ORAL CAVITY CANCER | 1 0.01 65.28 LIP DRY | 1 0.01 65.29 LIPID METABOLISM DISORDER | 1 0.01 65.30 LIPIDS INCREASED | 2 0.02 65.32 LIVER ABSCESS | 1 0.01 65.33 LIVER DISORDER | 1 0.01 65.34 LIVER TRANSPLANT | 16 0.16 65.50 LOCAL ANAESTHESIA | 4 0.04 65.54 LOCAL ANTIBACTERIAL THERAPY | 1 0.01 65.55 LOCALISED INFECTION | 2 0.02 65.57 LOCALISED OSTEOARTHRITIS | 14 0.14 65.71 LOW DENSITY LIPOPROTEIN INCREASED | 6 0.06 65.77 LOWER LIMB FRACTURE | 2 0.02 65.79 LOWER RESPIRATORY TRACT INFECTION | 4 0.04 65.83 LUMBAR SPINAL STENOSIS | 4 0.04 65.87 LUMBAR VERTEBRAL FRACTURE | 1 0.01 65.88 LUNG ADENOCARCINOMA | 6 0.06 65.94 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 3 0.03 65.97 LUNG DISORDER | 3 0.03 66.00 LUNG INFECTION | 4 0.04 66.04 LUNG INFILTRATION | 1 0.01 66.05 LUNG NEOPLASM MALIGNANT | 21 0.21 66.26 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 3 0.03 66.29 LUNG TRANSPLANT | 1 0.01 66.30 LUNG TRANSPLANT REJECTION | 2 0.02 66.32 LUPUS NEPHRITIS | 1 0.01 66.33 LYME DISEASE | 1 0.01 66.34 LYMPHADENITIS | 4 0.04 66.38 LYMPHOEDEMA | 1 0.01 66.39 LYMPHOMA | 8 0.08 66.47 MACULAR DEGENERATION | 3 0.03 66.50 MACULAR OEDEMA | 1 0.01 66.51 MAINTENANCE OF ANAESTHESIA | 3 0.03 66.54 MAJOR DEPRESSION | 16 0.16 66.70 MALABSORPTION | 5 0.05 66.75 MALAISE | 2 0.02 66.77 MALARIA | 3 0.03 66.80 MALARIA PROPHYLAXIS | 6 0.06 66.86 MALIGNANT MELANOMA | 10 0.10 66.96 MALIGNANT NEOPLASM OF RENAL PELVIS | 1 0.01 66.97 MANIA | 2 0.02 66.99 MATERNAL DRUGS AFFECTING FOETUS | 1 0.01 67.00 MEDICATION ERROR | 7 0.07 67.07 MEMORY IMPAIRMENT | 1 0.01 67.08 MENINGITIS | 2 0.02 67.10 MENINGITIS CRYPTOCOCCAL | 2 0.02 67.12 MENINGITIS TUBERCULOUS | 6 0.06 67.18 MENISCUS LESION | 1 0.01 67.19 MENORRHAGIA | 1 0.01 67.20 MENSTRUATION IRREGULAR | 2 0.02 67.22 MENTAL DISORDER | 1 0.01 67.23 MESOTHELIOMA | 6 0.06 67.29 MESOTHELIOMA MALIGNANT | 2 0.02 67.31 METABOLIC DISORDER | 1 0.01 67.32 METASTASES TO BONE | 20 0.20 67.52 METASTASES TO CENTRAL NERVOUS SYSTEM | 2 0.02 67.54 METASTASES TO LIVER | 6 0.06 67.60 METASTASES TO LUNG | 1 0.01 67.61 METASTASES TO PLEURA | 1 0.01 67.62 METASTASES TO STOMACH | 2 0.02 67.64 METASTATIC MALIGNANT MELANOMA | 3 0.03 67.67 METASTATIC NEOPLASM | 7 0.07 67.74 METASTATIC RENAL CELL CARCINOMA | 5 0.05 67.79 METRORRHAGIA | 1 0.01 67.80 MIGRAINE | 92 0.92 68.72 MIGRAINE PROPHYLAXIS | 5 0.05 68.77 MIGRAINE WITH AURA | 1 0.01 68.78 MINERAL SUPPLEMENTATION | 1 0.01 68.79 MITRAL VALVE PROLAPSE | 1 0.01 68.80 MITRAL VALVE REPLACEMENT | 2 0.02 68.82 MONARTHRITIS | 7 0.07 68.89 MOOD ALTERED | 1 0.01 68.90 MOOD SWINGS | 1 0.01 68.91 MOUTH ULCERATION | 2 0.02 68.93 MOVEMENT DISORDER | 1 0.01 68.94 MUCOPOLYSACCHARIDOSIS I | 2 0.02 68.96 MUCOSAL INFLAMMATION | 1 0.01 68.97 MULTIPLE ALLERGIES | 6 0.06 69.03 MULTIPLE GATED ACQUISITION SCAN | 1 0.01 69.04 MULTIPLE MYELOMA | 39 0.39 69.43 MULTIPLE SCLEROSIS | 274 2.74 72.17 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 72.18 MUSCLE CRAMP | 1 0.01 72.19 MUSCLE DISORDER | 1 0.01 72.20 MUSCLE RELAXANT THERAPY | 1 0.01 72.21 MUSCLE SPASMS | 3 0.03 72.24 MUSCLE SPASTICITY | 3 0.03 72.27 MUSCULOSKELETAL PAIN | 10 0.10 72.37 MUSCULOSKELETAL STIFFNESS | 2 0.02 72.39 MYALGIA | 7 0.07 72.46 MYASTHENIA GRAVIS | 3 0.03 72.49 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 5 0.05 72.54 MYELODYSPLASTIC SYNDROME | 4 0.04 72.58 MYELOFIBROSIS | 1 0.01 72.59 MYELOPROLIFERATIVE DISORDER | 1 0.01 72.60 MYOCARDIAL INFARCTION | 26 0.26 72.86 MYOCARDIAL ISCHAEMIA | 6 0.06 72.92 MYOPERICARDITIS | 1 0.01 72.93 NAIL TINEA | 21 0.21 73.14 NARCOLEPSY | 8 0.08 73.22 NASAL CONGESTION | 1 0.01 73.23 NASAL DRYNESS | 2 0.02 73.25 NASAL POLYPS | 1 0.01 73.26 NASOPHARYNGITIS | 18 0.18 73.44 NAUSEA | 12 0.12 73.56 NECK INJURY | 2 0.02 73.58 NECK PAIN | 8 0.08 73.66 NECROSIS | 2 0.02 73.68 NEOPLASM | 2 0.02 73.70 NEOPLASM MALIGNANT | 3 0.03 73.73 NEOPLASM PROPHYLAXIS | 1 0.01 73.74 NEPHRITIS | 1 0.01 73.75 NEPHROBLASTOMA | 5 0.05 73.80 NEPHROLITHIASIS | 1 0.01 73.81 NEPHROPATHY | 4 0.04 73.85 NEPHROTIC SYNDROME | 1 0.01 73.86 NERVE BLOCK | 1 0.01 73.87 NERVE COMPRESSION | 1 0.01 73.88 NERVOUS SYSTEM DISORDER | 1 0.01 73.89 NERVOUSNESS | 2 0.02 73.91 NEURALGIA | 5 0.05 73.96 NEUROBLASTOMA | 2 0.02 73.98 NEUROCYSTICERCOSIS | 1 0.01 73.99 NEUROMUSCULAR BLOCKADE REVERSAL | 1 0.01 74.00 NEUROPATHIC PAIN | 5 0.05 74.05 NEUROPATHY | 7 0.07 74.12 NEUROPATHY PERIPHERAL | 2 0.02 74.14 NEUROSIS | 1 0.01 74.15 NEUTROPENIA | 5 0.05 74.20 NEUTROPHIL COUNT DECREASED | 1 0.01 74.21 NON-HODGKIN'S LYMPHOMA | 14 0.14 74.35 NON-SMALL CELL LUNG CANCER | 51 0.51 74.86 NON-SMALL CELL LUNG CANCER RECURRENT | 1 0.01 74.87 NON-SMALL CELL LUNG CANCER STAGE III | 1 0.01 74.88 NON-SMALL CELL LUNG CANCER STAGE IIIA | 2 0.02 74.90 NON-SMALL CELL LUNG CANCER STAGE IV | 2 0.02 74.92 NORMAL DELIVERY | 1 0.01 74.93 NORMAL LABOUR | 1 0.01 74.94 NUCLEAR MAGNETIC RESONANCE IMAGING | 4 0.04 74.98 NUTRITIONAL SUPPORT | 4 0.04 75.02 OBESITY | 15 0.15 75.17 OBSESSIVE THOUGHTS | 2 0.02 75.19 OBSESSIVE-COMPULSIVE DISORDER | 2 0.02 75.21 OBSTRUCTIVE AIRWAYS DISORDER | 1 0.01 75.22 OEDEMA | 9 0.09 75.31 OEDEMA PERIPHERAL | 6 0.06 75.37 OESOPHAGEAL CARCINOMA | 6 0.06 75.43 OESOPHAGITIS | 1 0.01 75.44 OESTROGEN REPLACEMENT THERAPY | 2 0.02 75.46 OLIGODENDROGLIOMA | 3 0.03 75.49 ONYCHOMYCOSIS | 11 0.11 75.60 OPEN ANGLE GLAUCOMA | 3 0.03 75.63 OPEN WOUND | 1 0.01 75.64 ORAL CANDIDIASIS | 4 0.04 75.68 ORAL CONTRACEPTION | 5 0.05 75.73 ORAL FUNGAL INFECTION | 1 0.01 75.74 ORAL PAIN | 1 0.01 75.75 OROPHARYNGEAL CANCER STAGE UNSPECIFIED | 1 0.01 75.76 OSTEITIS DEFORMANS | 1 0.01 75.77 OSTEOARTHRITIS | 119 1.19 76.96 OSTEOCHONDROSIS | 1 0.01 76.97 OSTEOGENESIS IMPERFECTA | 1 0.01 76.98 OSTEOMYELITIS | 1 0.01 76.99 OSTEOPENIA | 1 0.01 77.00 OSTEOPOROSIS | 92 0.92 77.92 OSTEOPOROSIS PROPHYLAXIS | 11 0.11 78.03 OTITIS MEDIA | 2 0.02 78.05 OTITIS MEDIA CHRONIC | 1 0.01 78.06 OVARIAN CANCER | 38 0.38 78.44 OVARIAN CYST | 1 0.01 78.45 OVERDOSE | 3 0.03 78.48 OVULATION INDUCTION | 1 0.01 78.49 PAIN | 231 2.31 80.80 PAIN IN EXTREMITY | 16 0.16 80.96 PAIN IN JAW | 1 0.01 80.97 PAIN MANAGEMENT | 9 0.09 81.06 PALPITATIONS | 5 0.05 81.11 PANCREATIC CARCINOMA | 16 0.16 81.27 PANCREATIC CARCINOMA METASTATIC | 2 0.02 81.29 PANCREATIC CARCINOMA STAGE III | 1 0.01 81.30 PANIC ATTACK | 5 0.05 81.35 PANIC DISORDER | 8 0.08 81.43 PARAESTHESIA | 1 0.01 81.44 PARANOIA | 2 0.02 81.46 PARENTERAL NUTRITION | 3 0.03 81.49 PARKINSON'S DISEASE | 58 0.58 82.07 PARKINSONISM | 14 0.14 82.21 PAROSMIA | 1 0.01 82.22 PARTIAL SEIZURES | 3 0.03 82.25 PATENT DUCTUS ARTERIOSUS | 2 0.02 82.27 PELVIC INFECTION | 1 0.01 82.28 PELVIC INFLAMMATORY DISEASE | 1 0.01 82.29 PERIANAL ABSCESS | 1 0.01 82.30 PERIARTHRITIS | 2 0.02 82.32 PERICARDITIS | 2 0.02 82.34 PERICORONITIS | 3 0.03 82.37 PERIODONTAL OPERATION | 1 0.01 82.38 PERIODONTITIS | 2 0.02 82.40 PERIPARTUM CARDIOMYOPATHY | 1 0.01 82.41 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED | 3 0.03 82.44 PERITONEAL DIALYSIS | 1 0.01 82.45 PERITONITIS | 3 0.03 82.48 PERITONITIS BACTERIAL | 1 0.01 82.49 PERITONSILLITIS | 1 0.01 82.50 PERSONALITY DISORDER | 3 0.03 82.53 PETIT MAL EPILEPSY | 3 0.03 82.56 PHARYNGITIS | 3 0.03 82.59 PHLEBITIS | 1 0.01 82.60 PLANTAR FASCIITIS | 6 0.06 82.66 PLASMACYTOMA | 1 0.01 82.67 PLASMAPHERESIS | 1 0.01 82.68 PLATELET AGGREGATION | 2 0.02 82.70 PLEURAL EFFUSION | 1 0.01 82.71 PNEUMOCYSTIS CARINII PNEUMONIA | 9 0.09 82.80 PNEUMONIA | 59 0.59 83.39 PNEUMONIA ASPIRATION | 8 0.08 83.47 PNEUMONIA BACTERIAL | 5 0.05 83.52 PNEUMONIA CYTOMEGALOVIRAL | 4 0.04 83.56 PNEUMONIA LEGIONELLA | 3 0.03 83.59 POLYARTHRITIS | 9 0.09 83.68 POLYCYSTIC OVARIES | 1 0.01 83.69 POLYCYTHAEMIA VERA | 1 0.01 83.70 POLYMYALGIA | 2 0.02 83.72 POLYMYALGIA RHEUMATICA | 1 0.01 83.73 POLYNEUROPATHY | 2 0.02 83.75 POST HERPETIC NEURALGIA | 1 0.01 83.76 POST PROCEDURAL PAIN | 6 0.06 83.82 POST-TRAUMATIC STRESS DISORDER | 1 0.01 83.83 POSTMENOPAUSE | 1 0.01 83.84 POSTNASAL DRIP | 1 0.01 83.85 POSTOPERATIVE ANALGESIA | 2 0.02 83.87 POSTOPERATIVE CARE | 3 0.03 83.90 POSTOPERATIVE INFECTION | 1 0.01 83.91 POSTPARTUM DEPRESSION | 1 0.01 83.92 POSTPARTUM HAEMORRHAGE | 4 0.04 83.96 PRECOCIOUS PUBERTY | 1 0.01 83.97 PRECURSOR B-LYMPHOBLASTIC LYMPHOMA ST.. | 4 0.04 84.01 PREGNANCY | 2 0.02 84.03 PREMATURE BABY | 1 0.01 84.04 PREMATURE LABOUR | 5 0.05 84.09 PREMEDICATION | 24 0.24 84.33 PREOPERATIVE CARE | 2 0.02 84.35 PRINZMETAL ANGINA | 1 0.01 84.36 PROCTITIS | 2 0.02 84.38 PROCTITIS HERPES | 1 0.01 84.39 PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 84.40 PROLACTINOMA | 3 0.03 84.43 PROPHYLACTIC CHEMOTHERAPY | 2 0.02 84.45 PROPHYLAXIS | 82 0.82 85.27 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 9 0.09 85.36 PROPHYLAXIS AGAINST HIV INFECTION | 1 0.01 85.37 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 7 0.07 85.44 PROPHYLAXIS OF NAUSEA AND VOMITING | 6 0.06 85.50 PROSTATE CANCER | 27 0.27 85.77 PROSTATE CANCER METASTATIC | 15 0.15 85.92 PROSTATIC ADENOMA | 2 0.02 85.94 PROSTATIC DISORDER | 1 0.01 85.95 PROSTATITIS | 2 0.02 85.97 PROTEINURIA | 4 0.04 86.01 PRURITUS | 3 0.03 86.04 PSEUDOMONAS INFECTION | 3 0.03 86.07 PSORIASIS | 32 0.32 86.39 PSORIATIC ARTHROPATHY | 9 0.09 86.48 PSYCHOTIC DISORDER | 19 0.19 86.67 PULMONARY EMBOLISM | 8 0.08 86.75 PULMONARY HYPERTENSION | 36 0.36 87.11 PULMONARY TUBERCULOSIS | 11 0.11 87.22 PYELONEPHRITIS | 3 0.03 87.25 PYREXIA | 13 0.13 87.38 RADICULAR PAIN | 1 0.01 87.39 RADICULOPATHY | 1 0.01 87.40 RASH | 1 0.01 87.41 RAYNAUD'S PHENOMENON | 1 0.01 87.42 RECTAL CANCER | 11 0.11 87.53 REFLEX SYMPATHETIC DYSTROPHY | 6 0.06 87.59 REFLUX OESOPHAGITIS | 2 0.02 87.61 RENAL ARTERY STENOSIS | 2 0.02 87.63 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 2 0.02 87.65 RENAL DISORDER | 5 0.05 87.70 RENAL FAILURE | 1 0.01 87.71 RENAL FAILURE CHRONIC | 10 0.10 87.81 RENAL OSTEODYSTROPHY | 1 0.01 87.82 RENAL TRANSPLANT | 73 0.73 88.55 RESPIRATORY DISORDER | 1 0.01 88.56 RESPIRATORY FAILURE | 1 0.01 88.57 RESPIRATORY TRACT CONGESTION | 1 0.01 88.58 RESPIRATORY TRACT INFECTION | 4 0.04 88.62 RESTLESS LEGS SYNDROME | 7 0.07 88.69 RESTLESSNESS | 1 0.01 88.70 RETINAL VEIN OCCLUSION | 1 0.01 88.71 RETINOPATHY | 1 0.01 88.72 RHABDOMYOSARCOMA | 1 0.01 88.73 RHEUMATOID ARTHRITIS | 434 4.34 93.07 RHINITIS | 8 0.08 93.15 RHINITIS ALLERGIC | 6 0.06 93.21 RHINORRHOEA | 1 0.01 93.22 RIGHT VENTRICULAR FAILURE | 4 0.04 93.26 ROAD TRAFFIC ACCIDENT | 1 0.01 93.27 ROSACEA | 3 0.03 93.30 ROTATOR CUFF SYNDROME | 6 0.06 93.36 SALPINGO-OOPHORECTOMY BILATERAL | 1 0.01 93.37 SARCOIDOSIS | 2 0.02 93.39 SARCOMA | 3 0.03 93.42 SCHIZOAFFECTIVE DISORDER | 22 0.22 93.64 SCHIZOPHRENIA | 83 0.83 94.47 SCHIZOPHRENIA SIMPLE | 1 0.01 94.48 SCHIZOPHRENIA, DISORGANISED TYPE | 1 0.01 94.49 SCHIZOPHRENIA, PARANOID TYPE | 11 0.11 94.60 SCHIZOPHRENIA, RESIDUAL TYPE | 1 0.01 94.61 SCIATICA | 4 0.04 94.65 SCLERODERMA | 1 0.01 94.66 SEASONAL AFFECTIVE DISORDER | 1 0.01 94.67 SEASONAL ALLERGY | 2 0.02 94.69 SEBORRHOEA | 1 0.01 94.70 SEDATION | 44 0.44 95.14 SEDATIVE THERAPY | 1 0.01 95.15 SENILE DEMENTIA | 2 0.02 95.17 SEPSIS | 4 0.04 95.21 SEPTIC SHOCK | 3 0.03 95.24 SERUM SEROTONIN INCREASED | 1 0.01 95.25 SHOCK | 1 0.01 95.26 SHORT-BOWEL SYNDROME | 7 0.07 95.33 SHOULDER OPERATION | 3 0.03 95.36 SINUS DISORDER | 2 0.02 95.38 SINUS HEADACHE | 1 0.01 95.39 SINUSITIS | 21 0.21 95.60 SKIN INFECTION | 1 0.01 95.61 SKIN LESION | 1 0.01 95.62 SKIN NECROSIS | 1 0.01 95.63 SKIN PAPILLOMA | 1 0.01 95.64 SKIN ULCER | 3 0.03 95.67 SKIN WRINKLING | 9 0.09 95.76 SLEEP DISORDER | 7 0.07 95.83 SLEEP DISORDER THERAPY | 7 0.07 95.90 SMALL CELL CARCINOMA | 1 0.01 95.91 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 13 0.13 96.04 SMOKING CESSATION THERAPY | 10 0.10 96.14 SOCIAL PHOBIA | 2 0.02 96.16 SOFT TISSUE DISORDER | 1 0.01 96.17 SPINAL ANAESTHESIA | 5 0.05 96.22 SPINAL DISORDER | 2 0.02 96.24 SPINAL FRACTURE | 1 0.01 96.25 SPINAL FUSION ACQUIRED | 1 0.01 96.26 SPINAL OSTEOARTHRITIS | 2 0.02 96.28 SPONDYLITIS | 4 0.04 96.32 SPONDYLOARTHROPATHY | 2 0.02 96.34 SPONDYLOSIS | 7 0.07 96.41 SQUAMOUS CELL CARCINOMA | 6 0.06 96.47 STAPHYLOCOCCAL INFECTION | 8 0.08 96.55 STAPHYLOCOCCAL SEPSIS | 1 0.01 96.56 STATUS EPILEPTICUS | 6 0.06 96.62 STEM CELL TRANSPLANT | 15 0.15 96.77 STENT PLACEMENT | 3 0.03 96.80 STOMACH DISCOMFORT | 3 0.03 96.83 STREPTOCOCCAL INFECTION | 1 0.01 96.84 STRESS ECHOCARDIOGRAM | 4 0.04 96.88 STRESS INCONTINENCE | 1 0.01 96.89 STRESS SYMPTOMS | 2 0.02 96.91 STRESS ULCER | 1 0.01 96.92 SUBCUTANEOUS ABSCESS | 1 0.01 96.93 SUBDURAL HAEMATOMA | 2 0.02 96.95 SUICIDAL IDEATION | 1 0.01 96.96 SUICIDE ATTEMPT | 17 0.17 97.13 SUPERINFECTION LUNG | 1 0.01 97.14 SUPRAVENTRICULAR TACHYCARDIA | 2 0.02 97.16 SURGERY | 20 0.20 97.36 SURGICAL HAEMOSTASIS | 1 0.01 97.37 SUTURE INSERTION | 1 0.01 97.38 SWELLING | 3 0.03 97.41 SYNCOPE | 2 0.02 97.43 SYNOVITIS | 3 0.03 97.46 SYSTEMIC CANDIDA | 2 0.02 97.48 SYSTEMIC LUPUS ERYTHEMATOSUS | 6 0.06 97.54 SYSTEMIC MYCOSIS | 4 0.04 97.58 SYSTEMIC SCLEROSIS | 2 0.02 97.60 T-CELL LYMPHOMA | 5 0.05 97.65 T-CELL PROLYMPHOCYTIC LEUKAEMIA | 1 0.01 97.66 TACHYARRHYTHMIA | 1 0.01 97.67 TACHYCARDIA | 1 0.01 97.68 TAENIASIS | 1 0.01 97.69 TEMPORAL ARTERITIS | 1 0.01 97.70 TEMPORAL LOBE EPILEPSY | 5 0.05 97.75 TENDON DISORDER | 1 0.01 97.76 TENDONITIS | 5 0.05 97.81 TENOSYNOVITIS STENOSANS | 1 0.01 97.82 TENSION HEADACHE | 1 0.01 97.83 TERATOMA | 3 0.03 97.86 TESTICULAR PAIN | 1 0.01 97.87 TESTIS CANCER | 5 0.05 97.92 THALASSAEMIA | 1 0.01 97.93 THERMAL BURN | 1 0.01 97.94 THINKING ABNORMAL | 3 0.03 97.97 THROMBOCYTHAEMIA | 1 0.01 97.98 THROMBOSIS | 8 0.08 98.06 THROMBOSIS PROPHYLAXIS | 16 0.16 98.22 THYROID DISORDER | 10 0.10 98.32 THYROID GLAND CANCER | 2 0.02 98.34 THYROIDECTOMY | 1 0.01 98.35 TIBIA FRACTURE | 1 0.01 98.36 TINEA BLANCA | 1 0.01 98.37 TINEA INFECTION | 1 0.01 98.38 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 5 0.05 98.43 TONSILLECTOMY | 1 0.01 98.44 TONSILLITIS | 1 0.01 98.45 TOOTH EXTRACTION | 2 0.02 98.47 TOOTH INFECTION | 2 0.02 98.49 TOXOCARIASIS | 1 0.01 98.50 TOXOPLASMOSIS | 2 0.02 98.52 TRANSIENT ISCHAEMIC ATTACK | 7 0.07 98.59 TRANSMISSION OF DRUG VIA SEMEN | 2 0.02 98.61 TRANSPLANT | 1 0.01 98.62 TRAUMATIC SPINAL CORD COMPRESSION | 1 0.01 98.63 TREMOR | 3 0.03 98.66 TRIGEMINAL NEURALGIA | 5 0.05 98.71 TUBERCULIN TEST | 1 0.01 98.72 TUBERCULOSIS | 14 0.14 98.86 TUBERCULOSIS PROPHYLAXIS | 2 0.02 98.88 TUMOUR LYSIS SYNDROME | 2 0.02 98.90 TURNER'S SYNDROME | 1 0.01 98.91 TYPE IIA HYPERLIPIDAEMIA | 1 0.01 98.92 TYPE V HYPERLIPIDAEMIA | 1 0.01 98.93 ULCER | 2 0.02 98.95 UNEVALUABLE EVENT | 3 0.03 98.98 UPPER RESPIRATORY TRACT INFECTION | 9 0.09 99.07 UPPER RESPIRATORY TRACT INFLAMMATION | 3 0.03 99.10 URINARY INCONTINENCE | 1 0.01 99.11 URINARY RETENTION | 1 0.01 99.12 URINARY TRACT DISORDER | 2 0.02 99.14 URINARY TRACT INFECTION | 23 0.23 99.37 URINARY TRACT INFECTION BACTERIAL | 1 0.01 99.38 URINE BILIRUBIN DECREASED | 1 0.01 99.39 URINE OUTPUT DECREASED | 1 0.01 99.40 URTICARIA | 2 0.02 99.42 UTERINE CANCER | 2 0.02 99.44 UTERINE CONTRACTIONS ABNORMAL | 4 0.04 99.48 UTERINE LEIOMYOMA | 1 0.01 99.49 UVEITIS | 3 0.03 99.52 VARICES OESOPHAGEAL | 1 0.01 99.53 VASCULAR GRAFT OCCLUSION | 1 0.01 99.54 VASCULITIS NECROTISING | 3 0.03 99.57 VENOUS INSUFFICIENCY | 1 0.01 99.58 VENTRICULAR ARRHYTHMIA | 2 0.02 99.60 VENTRICULAR DYSFUNCTION | 1 0.01 99.61 VENTRICULAR TACHYCARDIA | 1 0.01 99.62 VERTIGO | 6 0.06 99.68 VIPOMA | 2 0.02 99.70 VIRAL INFECTION | 1 0.01 99.71 VIRILISM | 1 0.01 99.72 VITAMIN SUPPLEMENTATION | 6 0.06 99.78 VITILIGO | 1 0.01 99.79 VOLVULUS OF BOWEL | 4 0.04 99.83 VOMITING | 3 0.03 99.86 WEGENER'S GRANULOMATOSIS | 1 0.01 99.87 WEIGHT CONTROL | 3 0.03 99.90 WEIGHT DECREASED | 2 0.02 99.92 WHEEZING | 1 0.01 99.93 WOLFF-PARKINSON-WHITE SYNDROME | 2 0.02 99.95 WOUND | 3 0.03 99.98 WOUND INFECTION | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015